CEFIMELT-S 1.5 is a combination injectable antibiotic containing a third-generation cephalosporin with beta-lactamase inhibitor, effective against resistant gram-negative and mixed infections. This formulation is ideal for treating serious infections such as hospital-acquired infections, sepsis, and severe pneumonia, providing broad-spectrum coverage and enhanced efficacy in a convenient single vial for intravenous administration under medical supervision. This makes CEFIMELT-S 1.5 a critical option for healthcare providers managing complex infections in hospital settings.
CEFIMELT-S 1.5: Ceftriaxone + Sulbactam for Serious Infections
Category: Injections
Packaging: Single Vial
Composition: Ceftriaxone Sodium IP 1g + Sulbactam Sodium IP 500mg
Therapeutic Class: Antibiotic
Active Ingredient: Ceftriaxone 1g + Sulbactam 500mg
Strength: 1g/0.5g per vial
MRP: ₹227.50
Request InfoIntroduction
Uses & Indications
- Serious bacterial infections requiring IV therapy
- Hospital-acquired infections
- Sepsis and severe pneumonia
- Post-operative prophylaxis
- Resistant gram-negative infections
Contraindications
- Hypersensitivity to cephalosporins
- Severe renal disease
Side Effects
The side effects listed below may occur with the use of this medication. However, not all individuals experience these effects.
- Pain at injection site
- Phlebitis
- Nausea and vomiting
- Diarrhea
- Allergic reactions
Precautions
- Monitor renal function
- Reconstitute correctly
- IV administration required
Safety Advice & Precautions
- For intravenous or intramuscular use only
- Administer under medical supervision
- Check for hypersensitivity to penicillins
- Monitor renal function in elderly patients
- Use with caution in patients with liver disease
- Reconstitute with sterile water as directed
Storage Conditions
Store at 2-8°C. Protect from light.
Shelf Life & Expiry
24 months from date of manufacturing
Medical Disclaimer
This product information is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare professional before starting any new medication or changing your dosage. Rapid Pharmaceuticals is not responsible for any adverse effects resulting from the misuse of this medication.
